Description
The Department of Veterans Affairs intends to award a sole source contract to Medi-Physics, Inc. for the acquisition of DaTscan Radioactive Agent for Diagnostic Imaging. The Salt Lake City Healthcare System is currently experiencing production issues with their generic Ioflupane I-123, which has caused delays in patient scheduling and imaging. The contract aims to establish a reliable source of DaTscan I-123 to ensure timely completion of nuclear medicine orders.
• The contract will be awarded on a sole source basis to Medi-Physics, Inc.
• The Salt Lake City Healthcare System is currently sourcing generic Ioflupane I-123 from Cardinal Health radiopharmacy.
• The contract aims to circumvent production issues and ensure timely completion of nuclear medicine orders.
• Interested parties may identify their interest and capability to respond to this requirement by July 3rd, 2026.